바이오의약품 제3자 물류 시장 : 공급망, 서비스 유형별 - 세계 예측(2025-2030년)

The Biopharmaceutical Third Party Logistics Market was valued at USD 107.08 billion in 2023, expected to reach USD 121.77 billion in 2024, and is projected to grow at a CAGR of 14.20%, to USD 271.32 billion by 2030.

The biopharmaceutical third-party logistics (3PL) market plays a crucial role in efficiently managing and distributing biopharmaceutical products, providing end-to-end services including warehousing, transportation, and logistics technology tailored for temperature-sensitive and time-critical pharmaceuticals. The necessity of these services is driven by the increasing complexity of the global pharmaceutical supply chain and the need to adhere to stringent regulatory standards while ensuring the safe and efficient delivery of high-value biologics. Applications span across various end-use sectors including hospitals, specialized clinics, and pharmacies, facilitating the distribution of vaccines, monoclonal antibodies, and other biotech drugs. Growth in this market is being fueled by the rising demand for specialty medicines, advancements in logistics technology (like IoT and AI for real-time monitoring), and the expansion of biopharmaceutical production capacities. An emerging opportunity lies in the integration of blockchain for enhanced transparency and security in supply chains, which is increasingly appealing as the industry seeks to mitigate risk and improve compliance. However, the market faces limitations such as high operational costs due to the need for specialized infrastructure and the complexities associated with navigating constantly evolving regulations across different territories. Furthermore, scalability remains challenging due to the niche nature of many biopharmaceuticals requiring tailored storage and transport solutions. Innovation should focus on sustainable logistics solutions aimed at reducing carbon footprint, developing adaptive cold chain solutions, and enhancing data analytics capabilities for predictive logistics planning. The market is inherently competitive, characterized by strategic collaborations and mergers among logistics providers and biopharma companies seeking to optimize distribution networks. Stakeholders should prioritize investments in technology-driven solutions to improve operational efficiency and service differentiation, while also focusing on regional expansion strategies to tap into emerging markets with growing pharmaceutical needs.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biopharmaceutical Third Party Logistics Market

The Biopharmaceutical Third Party Logistics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing research and development (R&D) expenditure of pharmaceutical and biopharmaceutical industry
  • Rising need for temperature-controlled logistic services to transport biologics
  • Emerging trend of outsourcing logistics by various medical organizations
• Market Restraints
  • High costs of drug development and drug discovery procedures
• Market Opportunities
  • Growing technological advancements in biopharmaceutical third party logistics solutions
  • Rapidly growing need for the biosimilar medicines
• Market Challenges
  • Stringent governmental rules and regulations for international logistics procedures

Porter's Five Forces: A Strategic Tool for Navigating the Biopharmaceutical Third Party Logistics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biopharmaceutical Third Party Logistics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biopharmaceutical Third Party Logistics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biopharmaceutical Third Party Logistics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biopharmaceutical Third Party Logistics Market

A detailed market share analysis in the Biopharmaceutical Third Party Logistics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biopharmaceutical Third Party Logistics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biopharmaceutical Third Party Logistics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biopharmaceutical Third Party Logistics Market

A strategic analysis of the Biopharmaceutical Third Party Logistics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biopharmaceutical Third Party Logistics Market, highlighting leading vendors and their innovative profiles. These include Agility Public Warehousing Company K.S.C.P, AmerisourceBergen Corporation, C.H. Robinson Worldwide, Inc., CEVA Logistics AG, DB Schenker, DHL International GmbH, FedEx Corporation, Hitachi Transport System, Ltd., Kerry Logistics Network Ltd., Kuehne + Nagel International AG, McKesson Corporation, Nippon Express Co., Ltd., Schenker AG, Schneider National, Inc., SF Express Co., Ltd., United Parcel Service of America, Inc., and XPO Logistics, Inc..

Market Segmentation & Coverage

This research report categorizes the Biopharmaceutical Third Party Logistics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Supply Chain, market is studied across Cold Chain and Non-Cold Chain.
• Based on Service Type, market is studied across Transportation and Warehousing & Storage. The Transportation is further studied across Air Freight, Overland, and Sea Freight.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing research and development (R&D) expenditure of pharmaceutical and biopharmaceutical industry
    • 5.1.1.2. Rising need for temperature-controlled logistic services to transport biologics
    • 5.1.1.3. Emerging trend of outsourcing logistics by various medical organizations
  • 5.1.2. Restraints
    • 5.1.2.1. High costs of drug development and drug discovery procedures
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing technological advancements in biopharmaceutical third party logistics solutions
    • 5.1.3.2. Rapidly growing need for the biosimilar medicines
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent governmental rules and regulations for international logistics procedures
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Biopharmaceutical Third Party Logistics Market, by Supply Chain

• 6.1. Introduction
• 6.2. Cold Chain
• 6.3. Non-Cold Chain

7. Biopharmaceutical Third Party Logistics Market, by Service Type

• 7.1. Introduction
• 7.2. Transportation
  • 7.2.1. Air Freight
  • 7.2.2. Overland
  • 7.2.3. Sea Freight
• 7.3. Warehousing & Storage

8. Americas Biopharmaceutical Third Party Logistics Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Biopharmaceutical Third Party Logistics Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Biopharmaceutical Third Party Logistics Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agility Public Warehousing Company K.S.C.P
• 2. AmerisourceBergen Corporation
• 3. C.H. Robinson Worldwide, Inc.
• 4. CEVA Logistics AG
• 5. DB Schenker
• 6. DHL International GmbH
• 7. FedEx Corporation
• 8. Hitachi Transport System, Ltd.
• 9. Kerry Logistics Network Ltd.
• 10. Kuehne + Nagel International AG
• 11. McKesson Corporation
• 12. Nippon Express Co., Ltd.
• 13. Schenker AG
• 14. Schneider National, Inc.
• 15. SF Express Co., Ltd.
• 16. United Parcel Service of America, Inc.
• 17. XPO Logistics, Inc.